Underhill Investment Management Lowers stake in Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB) : Underhill Investment Management reduced its stake in Core Laboratories N.V. by 2.58% during the most recent quarter end. The investment management company now holds a total of 92,330 shares of Core Laboratories N.V. which is valued at $10,710,280 after selling 2,450 shares in Core Laboratories N.V. , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Core Laboratories N.V. makes up approximately 5.56% of Underhill Investment Management’s portfolio.

Other Hedge Funds, Including , American Century Companies Inc reduced its stake in CLB by selling 71,540 shares or 15.75% in the most recent quarter. The Hedge Fund company now holds 382,820 shares of CLB which is valued at $44,407,120. Core Laboratories N.V. makes up approx 0.05% of American Century Companies Inc’s portfolio.Cwm reduced its stake in CLB by selling 4,222 shares or 99.22% in the most recent quarter. The Hedge Fund company now holds 33 shares of CLB which is valued at $3,918. Nisa Investment Advisors added CLB to its portfolio by purchasing 8,205 company shares during the most recent quarter which is valued at $1,025,625. Core Laboratories N.V. makes up approx 0.01% of Nisa Investment Advisors’s portfolio.

Core Laboratories N.V. opened for trading at $115.15 and hit $117.15 on the upside on Friday, eventually ending the session at $116.81, with a gain of 0.30% or 0.35 points. The heightened volatility saw the trading volume jump to 4,13,452 shares. Company has a market cap of $5,152 M.

On the company’s financial health, Core Laboratories N.V. reported $0.35 EPS for the quarter, based on the information available during the earnings call on Jul 20, 2016. Analyst had a consensus estimate of $0.35. The company had revenue of $148.10 million for the quarter, compared to analysts expectations of $146.21 million. The company’s revenue was down -27.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.81 EPS.

Many Wall Street Analysts have commented on Core Laboratories N.V.. JP Morgan Initiated Core Laboratories N.V. on Jun 10, 2016 to “Overweight”, Price Target of the shares are set at $120.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Leave a Reply

Core Laboratories N.V. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Core Laboratories N.V.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.